Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report, we counted In-Vitro Diagnostics reagent.
The global In-Vitro Diagnostics market size is expected to reach US$ 87450 million by 2029, growing at a CAGR of 4.4% from 2023 to 2029. The market is mainly driven by the significant applications of In-Vitro Diagnostics in various end use industries. The expanding demands from the Diabetes, Infectious Diseases, Oncology and Cardiology, are propelling In-Vitro Diagnostics market. Tissue Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Professional Diagnostic segment is estimated at % CAGR for the next seven-year period.
The concentration of the market is relatively high, and the first 16 companies include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, JNJ, Sysmex, KHB, DaAn Gene, Leadman, BioSino, BSBE and Maccura, they occupied more than 66% of whole market. US dominates the market which occupied 43% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 7% of the whole market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for In-Vitro Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global In-Vitro Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global In-Vitro Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, In-Vitro Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of In-Vitro Diagnostics covered in this report include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD and JNJ, etc.
The global In-Vitro Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Global In-Vitro Diagnostics market, by region:
Global In-Vitro Diagnostics market, Segment by Type:
Global In-Vitro Diagnostics market, by Application
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of In-Vitro Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of In-Vitro Diagnostics
1.1 In-Vitro Diagnostics Market Overview
1.1.1 In-Vitro Diagnostics Product Scope
1.1.2 In-Vitro Diagnostics Market Status and Outlook
1.2 Global In-Vitro Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global In-Vitro Diagnostics Market Size by Region (2018-2029)
1.4 Global In-Vitro Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global In-Vitro Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, In-Vitro Diagnostics Market Size (2018-2029)
1.6.1 North America In-Vitro Diagnostics Market Size (2018-2029)
1.6.2 Europe In-Vitro Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific In-Vitro Diagnostics Market Size (2018-2029)
1.6.4 Latin America In-Vitro Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa In-Vitro Diagnostics Market Size (2018-2029)
2 In-Vitro Diagnostics Market by Type
2.1 Introduction
2.1.1 Tissue Diagnostics
2.1.2 Professional Diagnostic
2.1.3 Molecular Diagnostic
2.1.4 Diabetes Monitoring
2.1.5 Other
2.2 Global In-Vitro Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global In-Vitro Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global In-Vitro Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America In-Vitro Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe In-Vitro Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific In-Vitro Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America In-Vitro Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa In-Vitro Diagnostics Revenue Breakdown by Type (2018-2029)
3 In-Vitro Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Diabetes
3.1.2 Infectious Diseases
3.1.3 Oncology
3.1.4 Cardiology
3.1.5 HIV
3.1.6 Other
3.2 Global In-Vitro Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global In-Vitro Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global In-Vitro Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America In-Vitro Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe In-Vitro Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific In-Vitro Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America In-Vitro Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa In-Vitro Diagnostics Revenue Breakdown by Application (2018-2029)
4 In-Vitro Diagnostics Competition Analysis by Players
4.1 Global In-Vitro Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in In-Vitro Diagnostics as of 2022)
4.3 Date of Key Players Enter into In-Vitro Diagnostics Market
4.4 Global Top Players In-Vitro Diagnostics Headquarters and Area Served
4.5 Key Players In-Vitro Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 In-Vitro Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche In-Vitro Diagnostics Products, Services and Solutions
5.1.4 Roche In-Vitro Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Recent Developments
5.2 Siemens
5.2.1 Siemens Profile
5.2.2 Siemens Main Business
5.2.3 Siemens In-Vitro Diagnostics Products, Services and Solutions
5.2.4 Siemens In-Vitro Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Siemens Recent Developments
5.3 Abbott
5.3.1 Abbott Profile
5.3.2 Abbott Main Business
5.3.3 Abbott In-Vitro Diagnostics Products, Services and Solutions
5.3.4 Abbott In-Vitro Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Danaher Recent Developments
5.4 Danaher
5.4.1 Danaher Profile
5.4.2 Danaher Main Business
5.4.3 Danaher In-Vitro Diagnostics Products, Services and Solutions
5.4.4 Danaher In-Vitro Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Danaher Recent Developments
5.5 Thermo Fisher
5.5.1 Thermo Fisher Profile
5.5.2 Thermo Fisher Main Business
5.5.3 Thermo Fisher In-Vitro Diagnostics Products, Services and Solutions
5.5.4 Thermo Fisher In-Vitro Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Thermo Fisher Recent Developments
5.6 BioMerieux
5.6.1 BioMerieux Profile
5.6.2 BioMerieux Main Business
5.6.3 BioMerieux In-Vitro Diagnostics Products, Services and Solutions
5.6.4 BioMerieux In-Vitro Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 BioMerieux Recent Developments
5.7 Bio-Rad
5.7.1 Bio-Rad Profile
5.7.2 Bio-Rad Main Business
5.7.3 Bio-Rad In-Vitro Diagnostics Products, Services and Solutions
5.7.4 Bio-Rad In-Vitro Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Bio-Rad Recent Developments
5.8 BD
5.8.1 BD Profile
5.8.2 BD Main Business
5.8.3 BD In-Vitro Diagnostics Products, Services and Solutions
5.8.4 BD In-Vitro Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 BD Recent Developments
5.9 JNJ
5.9.1 JNJ Profile
5.9.2 JNJ Main Business
5.9.3 JNJ In-Vitro Diagnostics Products, Services and Solutions
5.9.4 JNJ In-Vitro Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 JNJ Recent Developments
5.10 Sysmex
5.10.1 Sysmex Profile
5.10.2 Sysmex Main Business
5.10.3 Sysmex In-Vitro Diagnostics Products, Services and Solutions
5.10.4 Sysmex In-Vitro Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Sysmex Recent Developments
5.11 KHB
5.11.1 KHB Profile
5.11.2 KHB Main Business
5.11.3 KHB In-Vitro Diagnostics Products, Services and Solutions
5.11.4 KHB In-Vitro Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 KHB Recent Developments
5.12 DaAn Gene
5.12.1 DaAn Gene Profile
5.12.2 DaAn Gene Main Business
5.12.3 DaAn Gene In-Vitro Diagnostics Products, Services and Solutions
5.12.4 DaAn Gene In-Vitro Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 DaAn Gene Recent Developments
5.13 Leadman
5.13.1 Leadman Profile
5.13.2 Leadman Main Business
5.13.3 Leadman In-Vitro Diagnostics Products, Services and Solutions
5.13.4 Leadman In-Vitro Diagnostics Revenue (US$ Million) & (2018-2023)
5.13.5 Leadman Recent Developments
5.14 BioSino
5.14.1 BioSino Profile
5.14.2 BioSino Main Business
5.14.3 BioSino In-Vitro Diagnostics Products, Services and Solutions
5.14.4 BioSino In-Vitro Diagnostics Revenue (US$ Million) & (2018-2023)
5.14.5 BioSino Recent Developments
5.15 BSBE
5.15.1 BSBE Profile
5.15.2 BSBE Main Business
5.15.3 BSBE In-Vitro Diagnostics Products, Services and Solutions
5.15.4 BSBE In-Vitro Diagnostics Revenue (US$ Million) & (2018-2023)
5.15.5 BSBE Recent Developments
5.16 Maccura
5.16.1 Maccura Profile
5.16.2 Maccura Main Business
5.16.3 Maccura In-Vitro Diagnostics Products, Services and Solutions
5.16.4 Maccura In-Vitro Diagnostics Revenue (US$ Million) & (2018-2023)
5.16.5 Maccura Recent Developments
6 North America
6.1 North America In-Vitro Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe In-Vitro Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific In-Vitro Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America In-Vitro Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa In-Vitro Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 In-Vitro Diagnostics Market Dynamics
11.1 In-Vitro Diagnostics Industry Trends
11.2 In-Vitro Diagnostics Market Drivers
11.3 In-Vitro Diagnostics Market Challenges
11.4 In-Vitro Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research